19-44908861-G-A
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP2
The NM_000041.4(APOE):c.565G>A(p.Glu189Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000132 in 1,520,730 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  7.3e-7   (  0   hom.  ) 
Consequence
 APOE
NM_000041.4 missense
NM_000041.4 missense
Scores
 2
 11
 6
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  2.85  
Publications
2 publications found 
Genes affected
 APOE  (HGNC:613):  (apolipoprotein E) The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016] 
APOE Gene-Disease associations (from GenCC):
- Alzheimer disease 2Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hyperlipoproteinemia type 3Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- lipoprotein glomerulopathyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
- sea-blue histiocyte syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
PM1
In a region_of_interest 8 X 22 AA approximate tandem repeats (size 175)  in uniprot entity APOE_HUMAN there are 12 pathogenic changes around while only 3 benign (80%) in NM_000041.4
PM2
Very rare variant in population databases, with high coverage; 
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 16 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 0.74028 (below the threshold of 3.09). Trascript score misZ: -1.1391 (below the threshold of 3.09). GenCC associations: The gene is linked to hyperlipoproteinemia type 3, sea-blue histiocyte syndrome, lipoprotein glomerulopathy, Alzheimer disease 2. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| APOE | NM_000041.4 | c.565G>A | p.Glu189Lys | missense_variant | Exon 4 of 4 | ENST00000252486.9 | NP_000032.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| APOE | ENST00000252486.9 | c.565G>A | p.Glu189Lys | missense_variant | Exon 4 of 4 | 1 | NM_000041.4 | ENSP00000252486.3 | ||
| APOE | ENST00000425718.1 | c.565G>A | p.Glu189Lys | missense_variant | Exon 3 of 3 | 1 | ENSP00000410423.1 | |||
| APOE | ENST00000434152.5 | c.643G>A | p.Glu215Lys | missense_variant | Exon 4 of 4 | 2 | ENSP00000413653.2 | |||
| APOE | ENST00000446996.5 | c.565G>A | p.Glu189Lys | missense_variant | Exon 4 of 4 | 2 | ENSP00000413135.1 | 
Frequencies
GnomAD3 genomes  0.00000658  AC: 1AN: 151908Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
151908
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00  AC: 0AN: 123130 AF XY:  0.00   
GnomAD2 exomes 
 AF: 
AC: 
0
AN: 
123130
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  7.31e-7  AC: 1AN: 1368822Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 675242 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
1
AN: 
1368822
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
0
AN XY: 
675242
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
0
AN: 
30336
American (AMR) 
 AF: 
AC: 
0
AN: 
34666
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
24542
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
34570
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
78482
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
33980
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
4116
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
1071316
Other (OTH) 
 AF: 
AC: 
0
AN: 
56814
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.375 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00000658  AC: 1AN: 151908Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74220 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
151908
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74220
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41426
American (AMR) 
 AF: 
AC: 
0
AN: 
15260
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4836
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10502
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
314
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
67914
Other (OTH) 
 AF: 
AC: 
0
AN: 
2086
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Uncertain 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Pathogenic 
 DEOGEN2 
 Benign 
T;T;.;. 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D;D 
 M_CAP 
 Pathogenic 
D 
 MetaRNN 
 Uncertain 
D;D;D;D 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Uncertain 
M;.;.;. 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Benign 
N;N;.;N 
 REVEL 
 Uncertain 
 Sift 
 Uncertain 
D;D;.;D 
 Sift4G 
 Benign 
T;T;T;T 
 Polyphen 
D;.;.;. 
 Vest4 
 MutPred 
Gain of MoRF binding (P = 0.0057);Gain of MoRF binding (P = 0.0057);.;Gain of MoRF binding (P = 0.0057);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.